Intrinsic Value

The intrinsic value of Pharmaniaga Bhd (PHARMA) under the Base Case is 1.108 MYR per share. Compared with the current market price of 0.845 MYR, the stock appears Undervalued by 24% .

The intrinsic value is calculated using the DCF method. The model assumes net margin rises from 1.2% last year to 1.9% by 2033, above its five-year average of -2.4%. Revenue grows about 6% a year over the next five years, below its five-year pace of 8%.

Do our valuations actually work? See backtest results .

PHARMA Intrinsic Value
1.108 MYR
Undervaluation 24%
Intrinsic Value
Price 0.845 MYR
P

PHARMA is cheaper than usual. It was this cheap or cheaper on just 16% of days in the past 5 years.

Monitor PHARMA
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value 0.89
Get notified when the price drops into your buy zone
Intrinsic Value 1.11
Margin of Safety 20% 0.89
Current Price 0.85
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to PHARMA

Fundamental Analysis

What Pharmaniaga Bhd Does

Health Care

Pharmaniaga Bhd is a Malaysian pharmaceutical company that makes, distributes, and supplies medicines and medical products. It serves two main jobs in the healthcare chain: producing some of its own products and moving a wide range of drugs and medical items from manufacturers to hospitals, clinics, pharmacies, and other healthcare customers.

Headquarters
Malaysia MY
Employees
3 502
IPO date
Nov 12, 1999
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Pharmaniaga Bhd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one PHARMA stock?

The intrinsic value for Pharmaniaga Bhd (PHARMA) under the Base Case is 1.108 MYR.

Is PHARMA stock undervalued or overvalued?

Compared with the current market price of 0.845 MYR, the stock appears Undervalued by 24% .

Back to Top